FundPlus
Fundplus is a long-term equity investment firm that focuses on life sciences companies.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed FundPlus Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Facebook
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Fundplus is a long-term equity investment firm that focuses on life sciences companies.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2012 | ITeos Therapeutics | Series A | 11.8M |
| 12/2021 | EyeD Pharma | Venture Round | 0 |
| 2/2022 | TargED Biopharmaceuticals | Series A | 0 |
| 11/2022 | Novadip Biosciences | Series B | 23.4M |
| 9/2017 | Immunic Therapeutics | Series A | 11.9M |
| 8/2022 | eTheRNA immunotherapies | Series B | 0 |
| 4/2020 | ITeos Therapeutics | Series B | 0 |
| 10/2021 | Novadip Biosciences | Series B | 0 |
| 10/2021 | Egle Therapeutics | Series A | 0 |
| 11/2017 | Coave Therapeutics | Series B | 22M |
| 12/2017 | Aelin Therapeutics | Series A | 31.8M |
| 10/2016 | Promethera Biosciences | Series C | 10.9M |
| 6/2018 | ITeos Therapeutics | Series B | 0 |
| 5/2022 | Tubulis | Series B | 0 |
| 7/2020 | ExeVir Bio | Series A | 0 |
| 9/2018 | Minoryx Therapeutics | Series B | 0 |
| 5/2019 | Confo Therapeutics | Series A | 33.6M |
| 6/2020 | eTheRNA immunotherapies | Series B | 0 |
| 6/2020 | Ona Therapeutics | Series A | 33.8M |
| 5/2022 | Minoryx Therapeutics | Series C | 0 |
| 8/2022 | AstriVax | Seed Round | 30M |
| 8/2021 | Cardior Pharmaceuticals | Series B | 0 |
| 5/2019 | EyeD Pharma | Funding Round | 31.3M |
| 1/2017 | OCTIMET Oncology | Series A | 12M |
| 7/2020 | Indigo Diabetes | Series B | 0 |
| 5/2022 | Minoryx Therapeutics | Series C | 0 |
| 5/2022 | Tubulis | Series B | 0 |
| 2/2022 | TargED Biopharmaceuticals | Series A | 0 |
| 12/2021 | EyeD Pharma | Venture Round | 0 |
| 10/2021 | Novadip Biosciences | Series B | 0 |
| 10/2021 | Egle Therapeutics | Series A | 0 |
| 8/2021 | Cardior Pharmaceuticals | Series B | 0 |
| 7/2020 | ExeVir Bio | Series A | 0 |
| 7/2020 | Indigo Diabetes | Series B | 0 |
| 6/2020 | Ona Therapeutics | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
